We provide you with 20 years of free, institutional-grade data for ICPT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ICPT. Explore the full financial landscape of ICPT stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2023-11-06 | 1270073 | ICPT | 10-Q | Url |
| 2023-08-02 | 1270073 | ICPT | 10-Q | Url |
| 2023-04-27 | 1270073 | ICPT | 10-Q | Url |
| 2023-03-02 | 1270073 | ICPT | 10-K | Url |
| 2022-11-01 | 1270073 | ICPT | 10-Q | Url |
| 2022-08-03 | 1270073 | ICPT | 10-Q | Url |
| 2022-05-06 | 1270073 | ICPT | 10-Q | Url |
| 2022-03-02 | 1270073 | ICPT | 10-K | Url |
| 2021-11-03 | 1270073 | ICPT | 10-Q | Url |
| 2021-07-29 | 1270073 | ICPT | 10-Q | Url |
| 2021-05-06 | 1270073 | ICPT | 10-Q | Url |
| 2021-02-25 | 1270073 | ICPT | 10-K | Url |
| 2020-11-09 | 1270073 | ICPT | 10-Q | Url |
| 2020-08-10 | 1270073 | ICPT | 10-Q | Url |
| 2020-05-11 | 1270073 | ICPT | 10-Q | Url |
| 2020-02-25 | 1270073 | ICPT | 10-K | Url |
| 2019-11-05 | 1270073 | ICPT | 10-Q | Url |
| 2019-08-08 | 1270073 | ICPT | 10-Q | Url |
| 2019-05-08 | 1270073 | ICPT | 10-Q | Url |
| 2019-03-01 | 1270073 | ICPT | 10-K | Url |
| 2018-11-01 | 1270073 | ICPT | 10-Q | Url |
| 2018-08-07 | 1270073 | ICPT | 10-Q | Url |
| 2018-05-10 | 1270073 | ICPT | 10-Q | Url |
| 2018-02-28 | 1270073 | ICPT | 10-K | Url |
| 2017-11-06 | 1270073 | ICPT | 10-Q | Url |
| 2017-08-03 | 1270073 | ICPT | 10-Q | Url |
| 2017-05-10 | 1270073 | ICPT | 10-Q | Url |
| 2017-03-01 | 1270073 | ICPT | 10-K | Url |
| 2016-11-09 | 1270073 | ICPT | 10-Q | Url |
| 2016-08-09 | 1270073 | ICPT | 10-Q | Url |
| 2016-05-10 | 1270073 | ICPT | 10-Q | Url |
| 2016-02-29 | 1270073 | ICPT | 10-K | Url |
| 2015-11-09 | 1270073 | ICPT | 10-Q | Url |
| 2015-08-07 | 1270073 | ICPT | 10-Q | Url |
| 2015-05-11 | 1270073 | ICPT | 10-Q | Url |
| 2015-03-02 | 1270073 | ICPT | 10-K | Url |
| 2014-11-06 | 1270073 | ICPT | 10-Q | Url |
| 2014-08-11 | 1270073 | ICPT | 10-Q | Url |
| 2014-05-09 | 1270073 | ICPT | 10-Q | Url |
| 2014-03-14 | 1270073 | ICPT | 10-K | Url |
| 2013-11-14 | 1270073 | ICPT | 10-Q | Url |
| 2013-10-01 | 1270073 | ICPT | S-1 | Url |
| 2013-08-13 | 1270073 | ICPT | 10-Q | Url |
| 2013-06-10 | 1270073 | ICPT | S-1 | Url |
| 2013-05-14 | 1270073 | ICPT | 10-Q | Url |
| 2013-04-01 | 1270073 | ICPT | 10-K | Url |
| 2012-11-26 | 1270073 | ICPT | 10-Q | Url |
| 2012-09-04 | 1270073 | ICPT | S-1 | Url |
Intercept Pharmaceuticals, Inc(NASDAQ:ICPT) 
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for t...
Website: http://www.interceptpharma.com
Founded: 2002
IPO Price: $15 (Oct 11, 2012)
Full Time Employees: 583
CEO: Jerry Durso
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ICPT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.